Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Curasight – Præsentation af helårsrapport 2023 og ny terapeutisk strategi

By HC Andersen Capital
Curasight

Mød og stil spørgsmål til Curasights CEO Ulrich Krasilnikoff og CSO Andreas Kjær, der vil gennemgå årsregnskabet for 2023 d. 27. februar kl. 10:30.

Herudover har Curasight efter årsafslutningen 2023 annonceret en kapitalforhøjelse med fortegningsret for eksisterende aktionærer som skal finansiere selskabets nye terapeutiske strategi. Fortegningsemissionen løber fra den 23. februar til den 7. marts.

Disclaimer: HC Andersen Capital modtager betaling fra Curasight for en DigitalIR/Corporate Visibility aftale./Claus Thestrup 13-02-2024 kl. 15.35.

Recent videos

Orion as an Investment | Life Science Night Dec. 9, 2025
2025-12-13 12:50 Orion
A sit-down with CEO Remco Westermann
2025-12-12 09:09 Verve Group
Aiforia as an Investment | Life Science Night Dec 9, 2025
2025-12-11 11:00 Aiforia Technologies
Endomines as an Investment | Investor Day Nov. 24, 2025
2025-12-10 12:30 Endomines Finland
Clas Ohlson, Audiocast, Q2'25
2025-12-10 09:00 Clas Ohlson
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.